baber/WOPTO huggingface dataset:
Patent NZ-596976-A (NZ)
Title: Sublingual dexmedetomidine compositions and methods of use thereof
Inventor: HENWOOD GERALDINE ANNE
IPC: A61K9/107
Filed: 2010-05-17
Abstract: 596976 The disclosure relates to a method of treating or preventing pain in a non-human mammal without significant sedation, said method comprising administering to a non-human mammal across oral mucosa thereof a dosage of dexmedetomidine or a pharmaceutically acceptable salt thereof (such as dexmedetomidine hydrochloride) in a range between about 0.05 μg per kg body weight and about 1.50 μg per kg body weight, wherein said dexmedetomidine or a pharmaceutically acceptable salt thereof is in a pharmaceutically acceptable vehicle (such as liquid water) for administration to an oral mucosa of the non-human mammal. Also disclosed are compositons for use in the method and dosage forms thereof. Forms of pain that may be treated with the methods include: idiopathic pain, neuralgia pain, myalgia pain, hyperalgia pain, hyperpathia pain, neuritis pain, neuropathic pain, pain associated with or caused by cancer, pain associated with or caused by viral infection, pain associated with or caused by physical trauma, pain associated with or caused by arthritis, headache pain, lower back pain, pain associated with or caused by surgery, pain associated with or caused by burn, or pain associated with or caused by blunt force trauma.
Patent NZ-597510-A (NZ)
Title: NOVEL ACETYLSALICYLIC ACID SALTS, the salts are 4-trimethylammoniobutanoate, L-carnitine and meldonium
Inventor: KALVINS IVARS
IPC: C07C229/12
Filed: 2010-06-21
Abstract: Disclosed are 4-trimethylammoniobutanoate, L-carnitine and 3-trimethylammonioamino propanoate (meldonium) acetylsalicylic acid addition salts, which are useful for treating heart and inflammation related diseases.
Patent NZ-598056-A (NZ)
Title: Blood coagulation protein conjugates
Inventor: TURECEK PETER
IPC: A61K47/48
Filed: 2010-07-26
Abstract: 598056 Discloses a modified blood coagulation protein comprising a)Factor IX (FIX) or Factor VIII (FVIII) and b) at least one polysialic acid (PSA) containing an active aminooxy group bound to said blood coagulation protein of (a); Wherein the blood coagulation protein has an oxime linkage between one or more oxidized carbohydrate moieties and the active aminooxy group on the PSA; wherein the protein has a specific activity of at least 50% relative to an unmodified blood coagulation protein.
Patent NZ-599171-A (NZ)
Title: Sulfonamides for the prevention of diabetes
Inventor: DAFFONCHIO LUISA
IPC: A61K31/185
Filed: 2010-10-06
Abstract: 599171 Disclosed herein is the use of sulfonamides of formula (I) wherein R and R1 are as defined in the description, for the preparation of medicaments for the prevention of diabetes, in particular of type-1 diabetes. The compounds are disclosed to protect pancreatic β-cells from structural and/or functional damage and to significantly delay the onset of diabetes as well as to reduce the severity of the disease, once this develops.
Patent NZ-601343-A (NZ)
Title: Oral liquid pharmaceutical composition of nifedipine
Inventor: JOSE MARIA BORRAS SCHIERLOH
IPC: A61K9/00
Filed: 2010-12-27
Abstract: 601343 Disclosed is an oral liquid pharmaceutical composition which is a solution comprising: a) nifedipine in an amount comprised between 0.1% and 1% w/w; b) ethanol in an amount comprised between 38% and 58% w/w; c) water in an amount comprised between 4% and 12% w/w; d) glycerine in an amount comprised between 30% and 50% w/w; and e) optionally, other pharmaceutical excipients or carriers; the sum total of components being 100% w/w, provided that the composition comprises amounts of between 0% to 0.1% w/w of polyethyleneglycol and of each derivative thereof, selected from polyethylene glycol alkyl ethers, polyethylene glycol fatty acid esters, polyethylene glycol sorbitan fatty acid esters and polyethylene glycol oxystearates, for use in stopping and/or treating preterm labour, angina, stroke, or Raynaud Syndrome.
Patent NZ-601877-A (NZ)
Title: Assembly for supporting a safety barrier
Inventor: DUNCAN GRAEME ANGUS GEORGE
IPC: E04G21/32
Filed: 2012-08-16
Abstract: 601877 An assembly for supporting a safety barrier typically around and under the eaves of a building has a bracket member 3 with a mounting portion 3a configured to be attached to a structure, a support member 7 pivotal relative to the bracket and with an abutment surface, and an adjustment member 11 pivotal relative to the bracket about an axis parallel to the support member pivotal axis and having abutment surfaces. The orientation of support member 7 relative to the bracket member 3 is adjustable by pivoting the adjustment member 11 and pivoting support member 7 such that a different one of the abutment surfaces of adjustment member 11 abuts the abutment surface of the support member 7.
Patent NZ-602821-A (NZ)
Title: Oral testosterone ester formulations and methods of treating testoterone deficiency comprising same
Inventor: DUDLEY ROBERT E
IPC: A61K47/44
Filed: 2010-04-12
Abstract: Disclosed is an oral pharmaceutical composition comprising testosterone undecanoate solubilized in a carrier comprising at least one lipophilic surfactant (preferably oleic acid) and at least one hydrophilic surfactant (preferably polyoxyethyleneglycerol-trihydroxy-stearate (Cremophor RH 40)) in a total lipophilic surfactant to total hydrophilic surfactant ratio (w/w) falling in the range of about 6: 1 to 3.5: 1, wherein said solubilized testosterone undecanoate comprises 18 to 22 percent by weight of the composition, which composition, upon once- or twice-daily oral administration, provides an average serum testosterone concentration at a steady state falling in the range of about 300 to about 1100 ng/dL.
Patent NZ-626572-A (NZ)
Title: Telescopic rotor blade and telescopic tower, wind turbine, and wind farm
Inventor: ROHDEN ROLF
IPC: F03D7/02
Filed: 2012-12-28
Abstract: Disclosed is a rotor blade (101) with a first rotor blade section (103) and a second rotor blade section (105). The first rotor blade section and the second rotor blade section are designed to be displaceable relative to each other by means of a control device (109, 113), so a telescopic rotor blade is formed and the rotor blade sections can adopt a minimum position, an intermediate position or a maximum position when displaced. The rotor blade includes a reset device (115), which is setup in such a manner that in case of a functional limitation of the control device, the rotor blade sections take up the minimum position.
Patent NZ-702571-A (NZ)
Title: 4-(substituted-amino)-7h-pyrrolo[2,3-d]pyrimidines as lrrk2 inhibitors
Inventor: GALATSIS PAUL
IPC: C07D519/00
Filed: 2013-06-19
Abstract: The present invention provides 4,5-disubstituted-7H-pyrrolo[2,3-d]pyrimidine derivatives of Formula I, and the pharmaceutically acceptable salts thereof wherein R1, R2, R3, R4 and R5 are as defined in the specification. The invention is also directed to pharmaceutical compositions comprising the compounds of formula I and to use of the compounds in the treatment of diseases associated with LRRK2, such as Parkinson’s disease.
Patent NZ-712214-A (NZ)
Title: Systems and methods for detection of cognitive and developmental conditions
Inventor: KLIN AMI
IPC: A61B3/113
Filed: 2014-03-11
Abstract: Developmental disorders such as autism spectrum disorders (ASD) affect nearly 14% of children in the United States. Diagnostic methods for conditions such as ASD vary considerably, and even the use of “best practice” tools provides rather poor sensitivity and specificity to the conditions. Late diagnosis of developmental disabilities reduces effectiveness of treatments and often results in poor outcomes. Furthermore, treatment providers (e.g., pediatricians or other medical professionals) lack adequate tools for measuring progress in these conditions. In accordance with the present invention, there is provided a system comprising: a display device; a sensor for detecting eye movement of a subject in response to a stimulus displayed by the display device; a support device for seating the subject, wherein the support device is adjustable to position the subject in an orientation with respect to the display device and the sensor that allows for collection of eye movement data, and wherein the support device, once positioned, confines the subject in said orientation; and a frame that supports each of the display device, the sensor for detecting eye movement of the subject, and the support device for seating the subject. The present invention also provides a system comprising: a frame comprising a first end opposite a second end, wherein the frame supports: a display affixed to the first end; a sensor proximate the display that detects ocular behavior of a subject in relation to a stimulus on the display; and a device that is affixed to the second end and positions the subject in an orientation such that the subject can view the display and that allows for collection of data, via the sensor, associated with ocular behavior of the subject in relation to the stimulus on the display. he present invention also provides a system comprising:a frame; a display affixed to the frame and configured for displaying a stimulus to a subject; a sensor proximate the display that detects ocular behavior of the subject in relation to the stimulus on the display; and a positioning device that positions the subject in an orientation such that the subject can view the display and that allows for collection of data, via the sensor, associated with ocular behavior of the subject in relation to the stimulus on the display.
Patent NZ-712319-A (NZ)
Title: Methods of seed treatments and resulting products
Inventor: JASON JOHN WARGENT
IPC: A61N5/06
Filed: 2014-09-17
Abstract: The present invention relates to a method of treating a seed for sowing with UV-B irradiation to improve subsequent plant performance. The invention relates also to subsequent plants or harvestable crop materials resulting from treatment of seeds for sowing with UV-B irradiation.
Patent NZ-735378-A (NZ)
Title: Heterocyclylamines as pi3k inhibitors
Inventor: ZHU WENYU
IPC: C07D471/04
Filed: 2012-08-31
Abstract: Provided are bicyclic heterocyclylamine derivative compounds, of the general formula I, wherein the variables are as defined in the specification. Examples of the compounds include 1-{ 1-[5-Chloro-3-(1-isopropylazetidin-3-yl)-2-methoxy-4-methylphenyl)ethyl} -3-methyl-1H-pyrazolo[3,4-d)pyrimidin-4-amine bis(trifluoroacetate) and 5-{ 3-[1-(4-Amino-6-methyl-5-oxopyrido[2,3-d)pyrimidin-8(5H)-yl)ethyl)-5-chloro-2-methoxy-6-methylphenyl} -N,N-dimethylpyridine-2-carboxamide bis(trifluoroacetate). The compounds are inhibitors of phosphoinositide 3-kinases (PI3Ks). The compounds are useful in the treatment of cancer, inflammatory diseases and immune diseases.
Patent NZ-744037-A (NZ)
Title: Power conversion system and power conversion device
Inventor: IWAMATSU YUSUKE
IPC: H02M7/5387
Filed: 2016-11-28
Abstract: When supplying alternating-current power to a load cut off from a utility power grid from a plurality of power conversion devices connected in parallel, if the plurality of power conversion devices are driven using the clamping method, distortion of the output voltage in the zero-crossover period increases due to dead-time. This negatively influences the load when it detects the zero-crossover and undergoes synchronization control. The more units there are operating in parallel, the bigger the output load is, and the bigger the zero-crossover distortion is. The present invention therefore aims to provide a power conversion system and power conversion device capable of inhibiting zero-crossover distortion and performing high-efficiency power conversion when operating in parallel. An aspect of the present invention may broadly comprise: A bridge circuit (21) converts input direct-current voltage and outputs alternating-current voltage. A filter circuit (23) attenuates a high-frequency component of the alternating-current voltage output from the bridge circuit (21). A clamping circuit (22) is disposed between the bridge circuit (21) and the filter circuit (23), and is capable of short-circuiting the output side of the bridge circuit (21). A control circuit (24) has a first mode in which a switching element causes the alternating-current voltage to be output to the filter circuit (23) at three or more voltage levels, and a second mode in which the switching element causes the alternating-current voltage to be output to the filter circuit (23) at two voltage levels. When power conversion devices (20) have their alternating-current side output paths connected and operate in parallel, at least one of the power conversion devices (20) operating in parallel operates in the second mode.
Patent NZ-744628-A (NZ)
Title: Container compressing arrangement and method of operating a container compressing arrangement
Inventor: JENTER HOLGER
IPC: B30B9/16
Filed: 2017-02-17
Abstract: Container compressing arrangement (100), mountable in a reverse vending machine, for compacting empty containers, in particular beverage bottles or cans which are preferably made of plastic or metallic material, such as PET or tinned metal, said container compressing arrangement comprising: a first and a second rotatable roller (102, 104), each of said rollers having a working surface (122) arranged between two oppositely arranged ends (110a-110b, 110c-110d), wherein said rollers are arranged adjacent to each other to rotate in opposite directions around a respective rotation axis (106, 108) in a common geometrical xz-plane (x-z); and wherein said working surface (122) comprises a plurality of ridges extending across said working surface, in an axial direction of said roller, and distributed in the circumferential direction of said working surface, each ridge (120) having a longitudinal extension in said axial direction, wherein at least one of said ridges of at least one roller is provided with recesses (126) extending in the axial direction, and wherein the recesses form a clearance between the rollers in the x‐direction.
Patent NZ-753462-A (NZ)
Title: Goods transport facility
Inventor: FUJIO YOSHIHIKO
IPC: B65G35/06
Filed: 2017-09-07
Abstract: The present invention relates to a goods transport facility for transporting goods along a transportation path having a curved portion, and more particularly to a goods transport facility that is provided with a plurality of transport carriages for transporting goods by moving along a pair of right and left rails provided along the transportation path. The rollers and the wheels have different axes of rotation. The carriages have wheels that rotate on the rails to support the carriages, and side rollers that face each rail and limit lateral movement of the carriage. At least either a curve shift region 40a or an S-curve region 40b of the curved portion of the transportation path is provided with a rail width adjusting mechanism 50 capable of changing the rail width between left and right rails 30L, 30R. The rail width reduction prevents banging of the side rollers with the rails
Patent NZ-758180-A (NZ)
Title: Unobtrusive nasal mask
Inventor: BARLOW ADAM
IPC: A61M16/06
Filed: 2010-06-02
Abstract: A patient interface 200 for delivering pressurized breathable gas to a patient comprising a flexible sealing portion 210 that is configured to sealingly engage with an exterior of the patient’s nose, and a pair of nozzles 320 protruding from the flexible sealing portion and configured to be inserted into the patient’s nostrils in use. The sealing portion 210 comprises a pair of resiliently flexible lateral sides and a central part between the lateral sides, with the central part comprising a septum locator 326 configured to engage with the patient’s septum, and the pair of lateral sides configured to be outwardly flexed by the patient’s nose. Each nozzle 320 has a central longitudinal axis, a base end at the flexible sealing portion and a discharge end 322 opposite to the base end, and tapers from the base end toward the discharge end. The septum locator 326 is positioned between the pair of nozzles 320, and the pair of lateral sides of the sealing portion are configured to pivot at the septum locator 326 when outwardly flexed by the patient’s nose. The pair of nozzles 320 are configured so that the discharge ends 322 of the nozzles 320 move away from each other when the lateral sides of the flexible sealing portion are outwardly flexed by the patient’s nose.
Patent NZ-758289-A (NZ)
Title: Drug regulated transgene expression
Inventor: JENSEN MICHAEL
IPC: C07K14/725
Filed: 2015-04-08
Abstract: The present invention provides nucleic acids, vectors, host cells, methods and compositions to confer and/or augment immune responses mediated by cellular immunotherapy, such as by adoptively transferring CD8+ central memory T cells or combinations of central memory T cells with CD4+ T cells that are genetically modified to express a chimeric receptor under the control of an inducible promoter. In some alternatives the genetically modified host cell comprises a nucleic acid comprising a polynucleotide coding for a chimeric antigen receptor comprising a ligand binding domain, a polynucleotide comprising a spacer region, a polynucleotide comprising a transmembrane domain, and a polynucleotide comprising an intracellular signaling domain under the control of a drug inducible promoter. Controlling the expression of the chimeric receptor provides for the ability to turn expression on and off depending on the status of the patient. Pharmaceutical formulations produced by the method, and methods of using the same, are also described.
Patent PT-103954-A (PT)
Title: Processo para o fabrico de doçarias de figo e doçarias assim obtidas.
Inventor: RODRIGUES MARIA HELENA DA SILV
IPC: A23L21/12
Filed: 2008-02-01
Abstract: A PRESENTE INVENÇÃO DIZ RESPEITO A UM PROCESSO PARA O FABRICO DE DOÇARIAS DE FIGO, EM ESPECIAL FIGOS SECOS APÓS COZEDURA E GELEIA OU DOCE DE FIGO. NESTE PROCESSO, OS FIGOS, RECENTEMENTE COLHIDOS, SÃO PICADOS, COZIDOS EM AÇÚCAR EM PONTO DE PÉROLA E SECOS AO AR, OBTENDO-SE AINDA COMO SUBPRODUTO GELEIA OU DOCE DE FIGO. A INVENÇÃO DIZ AINDA RESPEITO AOS FIGOS E À GELEIA OU DOCE DE FIGO OBTIDOS.
Patent PT-106561-A (PT)
Title: Método implementado em computador para acesso seguro a redes wlan, mais concretamente wi-fi
Inventor: MATOS ALFREDO MIGUEL MELO
IPC: G06F21/42
Filed: 2012-10-02
Abstract: A PRESENTE INVENÇÃO DIZ RESPEITO A UM MÉTODO IMPLEMENTADO EM DISPOSITIVO COMPUTACIONAL (COMPUTADOR, SMARTPHONE, TABLET OU SIMILAR) PARA ACESSO SEGURO A REDES WLAN, MAIS CONCRETAMENTE WI-FI, O QUAL CONSISTE NUM SISTEMA DE AUTENTICAÇÃO DE ACESSO À INTERNET SEM FIOS WI-FI QUE SE BASEIA NUM CANAL LATERAL DE NEAR FIELD COMMUNICATIONS (NFC) (COMUNICAÇÕES EM CAMPO PRÓXIMO (NFC) ). DESTINA-SE A RESOLVER OS PROBLEMAS DE SEGURANÇA DE CONFIGURAÇÃO DE WI-FI E ACESSO EM LOCAIS PÚBLICOS. A PRESENTE INVENÇÃO DEFINE UMA ARQUITETURA QUE SIMPLIFICA A CONFIGURAÇÃO DO PONTO DE ACESSO WI-FI PARA O UTILIZADOR FINAL E SIMULTANEAMENTE, AUMENTA A SEGURANÇA DO UTILIZADOR E A PRIVACIDADE EM REDES PÚBLICAS. ESTE OBJETIVO É CONSEGUIDO ATRAVÉS DA INCORPORAÇÃO DE REDE E INFORMAÇÃO DE SEGURANÇA EM DISPOSITIVOS HABILITADOS PARA NFC, QUE PERMITEM AO UTILIZADOR CONECTARSE A REDES SEM FIOS SEGURAS SEM QUE EXISTA UMA RELAÇÃO PRÉESTABELECIDA. A UTILIZAÇÃO DE UM SISTEMA CRIPTOGRÁFICO ASSIMÉTRICO, PERMITE ABORDAR VÁRIAS AMEAÇAS À SEGURANÇA, TAIS COMO ATAQUE POR EVIL TWIN (GÉMEO MAL INTENCIONADO), ATAQUES POR INTERCEPÇÃO/ESCUTAS EM PONTO DE ACESSO PÚBLICOS À INTERNET SEM FIOS OU EM PORTAL CATIVO, E ATÉ MESMO ATAQUES POR MAN-IN-THE-MIDDLE (HOMEM-NO-MEIO).
Patent RU-94001080-A (RU)
Inventor: KULAGIN V F
IPC: A61K38/21
Filed: 1994-01-12
Abstract: FIELD: medicinal industry, virology. SUBSTANCE: method involves the use of Newcastle disease virus (strain "H") which is administrated into chick embryo allantois cavity at concentration "10-10ЦПД"/50/ml. Embryos were incubated at (37±0.5) C for 48 hr, cooled at 4 C and allantois fluid is removed. Prepared virus-inductor does not show cytopathic effect on leukocytes. EFFECT: decreased cytopathic action, enhanced interferon-inducing activity.
Patent RU-94017981-A (RU)
Inventor: KHVOSTOV E D
IPC: G01M17/04
Filed: 1994-05-16
Abstract: FIELD: automotive industry. SUBSTANCE: method comprises measuring static load exerted by wheel on the vibration area, vibrating the wheel in a frequency range which includes a resonance frequency of the vehicle without springs, measuring the amplitude of vertical dynamic contact loads between the wheel and vibrating area, recording minimum value of the vertical dynamic contact loads between the wheel and vibration area on reaching steady-state forced oscillation, and measuring a minimum value of vertical dynamic contact loads between the wheel and vibration area at resonance. The efficiency of the shock-absorber is determined by a relationship presented in the invention description. EFFECT: improved accuracy of determining. 2 cl, 1 dwg
Patent RU-94022737-A (RU)
Inventor: BONDAREV A A
IPC: C02F3/08
Filed: 1994-06-23
Abstract: FIELD: sewage cleaning. SUBSTANCE: invention relates of combined equipment meant for treatment of sewage and may be used for high-efficiency biological cleaning and aftercleaning of town and industrial discharges close to them by composition from organic substances and biogenic elements. Biosorber is manufactured in the form of tower reactor with cylindrical housing with expanded upper and conical lower parts. Lower part of housing is provided with peripheral filtration chamber having layer of filtering charge, drainage system in the form of double semi-ring pipe-lines with branch pipes and pipe-line for discharge of cleaned water and conical water distributor mounted above pipe-line that feeds water for treatment. Expanding upper part is provided with device for removal of excessive active silt fabricated in the form of funnel coupled to pipe-line for removal of excessive active silt. Lower part of housing is fitted with supporting bars with locators which carry system of coaxially arranged drums with fiber packing applied to them, with system of collection of clarified water carrying vertical pipes mounted on support rods arranged over internal perimeter of expanded part of housing. Holes are uniformly distributed over their entire height. Biosorber has collecting pipe-line coupled to upper branch pipes of vertical pipes, pipe-line to discharge clarified water, system of discharge of recirculated water made in the form of funnel joined to pipe-line of recirculated flow, system of water saturation with oxygen fabricated in the form of ejector and saturator mounted in series on pipe-line of recirculated flow. EFFECT: simplified design, enhanced cleaning efficiency. 3 dwg
Patent RU-94026080-A (RU)
Inventor: TEJERT MARSELLIN PLEKHEL M GERKHARD
IPC: C07B61/00
Filed: 1994-07-18
Abstract: FIELD: chemical technology. SUBSTANCE: method of e-caprolactam purification involves the hydrogenization of mixture water-e-caprolactam with hydrogen in the presence of catalyst of heterogeneous hydrogenization. Mixture e-caprolactam-water contacts with gaseous hydrogen, hydrogen is dissolved in mixture e-caprolactam-water and then this hydrogen-containing mixture contacts with hydrogenization catalyst and 90-100% hydrogen in the process of hydrogenization is dissolved in mixture water-e-caprolactam. EFFECT: improved method of purification.